Search clinical trials for: AZD9833 with palbociclib
Total 17441 results
-
AstraZenecaActive, not recruitingER+ HER2- Advanced Breast CancerUnited States, Spain, United Kingdom
-
AstraZenecaQuotient SciencesCompletedHealthy VolunteersUnited Kingdom
-
AstraZenecaActive, not recruitingER+ HER2- Advanced Breast CancerJapan
-
AstraZenecaCompletedHepatic ImpairmentUnited States, Bulgaria, Slovakia
-
AstraZenecaRecruitingER+ HER2- Advanced Breast Cancer | High-grade Serous Ovarian Cancer (HGSOC)Korea, Republic of, United Kingdom, Australia, United States, Spain
-
AstraZenecaCompletedHER2-negative Breast CancerMexico, United Kingdom, Georgia
-
AstraZenecaCompletedHealthy Volunteers | Alzheimer's Disease | Tolerability | Safety | Blood ConcentrationUnited Kingdom
-
AstraZenecaParexelRecruitingDilated CardiomyopathyUnited States
-
AstraZenecaActive, not recruitingER-Positive HER2-Negative Breast CancerAustria, Belgium, France, Germany, Italy, United Kingdom, United States, Canada, India, Taiwan, Russian Federation, Korea, Republic of, Hungary, Japan, Mexico, Turkey, China, Malaysia, Spain, Czechia, Portugal, Poland, Norway, Bulgaria, Slovaki... and more
-
AstraZenecaTerminated
-
PfizerActive, not recruiting
-
AstraZenecaRecruitingER-Positive HER2-Negative Breast CancerUnited States, Israel, Spain, Korea, Republic of, Italy, Poland, Belgium, Norway, Bulgaria, France, Germany, United Kingdom, Japan, Taiwan, Canada, Hungary, Australia, Austria, Portugal, Turkey, Russian Federation, Slovakia, Switzer...
-
Sudipto MukherjeeActive, not recruitingAcute Myeloid Leukemia | AMLUnited States
-
AstraZenecaRecruitingHematological MalignanciesUnited States, Spain, Korea, Republic of, Italy, Japan, Taiwan, Australia, Germany, China
-
AstraZenecaParexelCompleted
-
AstraZenecaQuotient SciencesCompletedER-positive, HER2-negative Breast CancerUnited Kingdom
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruiting
-
AstraZenecaParexelTerminated
-
AstraZenecaParexelCompleted
-
AstraZenecaCompletedAdvanced Solid MalignanciesRussian Federation, Germany
-
AstraZenecaCompletedHealthyUnited Kingdom
-
AstraZenecaCompleted
-
AstraZenecaCompletedHeart Failure With Preserved Ejection FractionUnited States, France, Netherlands, Belgium, Taiwan, Slovakia, Japan, Czechia, Hungary, Australia, Bulgaria, Poland, Russian Federation, Brazil, Denmark, Turkey, Sweden, Canada
-
AstraZenecaParexelCompletedHeart Failure With Preserved Ejection Fraction (HFpEF)United States
-
Arvinas Estrogen Receptor, Inc.PfizerRecruiting
-
PfizerCompleted
-
AstraZenecaParexelCompleted
-
AstraZenecaCompletedHealthyUnited Kingdom
-
AstraZenecaTerminatedHeart FailureDenmark, Finland, Netherlands, United States, Sweden
-
AstraZenecaRecruitingChronic Obstructive Pulmonary Disease (COPD)United States, Canada, Denmark, Germany, South Africa, Spain, United Kingdom, Italy, Argentina, Bulgaria, Mexico, Turkey, Poland, Netherlands
-
AstraZenecaCompleted
-
Mayo ClinicNational Center for Advancing Translational Sciences (NCATS)Completed
-
PfizerCompleted
-
AstraZenecaRecruitingCOVID-19 | SARS-CoV-2 InfectionUnited States
-
AstraZenecaParexelTerminated
-
AstraZenecaCompletedNon-Cirrhotic Non-alcoholic Steatohepatitis With FibrosisDenmark, Italy, Spain, United States, Argentina, Sweden, Mexico, Norway, Portugal
-
AstraZenecaParexelCompletedCardiovascular DiseaseUnited States
-
AstraZenecaCompleted
-
AstraZenecaCompletedAdvanced Solid Malignancies | Breast Cancer - ER+, HER2 - | Breast Cancer - ER+, HER2-, PIK3CA Gene MutationUnited States, United Kingdom
-
MegalabsNot yet recruiting
-
PfizerCompletedHealthyUnited States
-
AstraZenecaQuotient SciencesCompletedCardiovascular DiseaseUnited Kingdom
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingInhibition of Autophagy Synergizes Anti-tumor EffectChina
-
Memorial Sloan Kettering Cancer CenterPfizerCompletedSarcoma | LiposarcomaUnited States
-
AstraZenecaCompletedSeptic Shock | Severe SepsisCzech Republic, France, Spain, Finland, Canada, Australia, Belgium